For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

The strategy, known as synthetic biology, is gaining momentum globally as a conservation tool and human health solution, ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

Two studies published in Nature Medicine June 11 contribute to a small body of literature suggesting cells edited with CRISPR-Cas9 may cause cancer. Here are five things to know about the studies and ...

In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to ...

New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.

Discover the innovative TECHNO platform for full-length gene humanisation, enhancing models for human gene function.

Joint Statement by Ralph J. Cicerone and Victor J. Dzau WASHINGTON -- The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making ...

In today’s installment of “hey please don’t do that,” the Wall Street Journal reports that a clandestine startup named Preventive is trying to usher in the first known birth of a genetically-modified ...